New consortium working to boost vaccine production in South Africa

SOUTH AFRICA – The World Health Organization (WHO), together with a few other concerned organizations have formed a consortium, officiated by a letter of intent to address the global imbalance of manufacturing capacity for COVID-19 vaccines. The consortium, consisting of the Medicines Patent Pool (MPP), Afrigen Biologics (PTY) Limited, the Biologicals and Vaccines Institute of Southern Africa (Biovac), the South African Medical Research Council (SAMRC) and Africa Centres for Disease Control and Prevention (Africa CDC), will establish the South African mRNA technology transfer hub. This hub will allow for greater…

Read More

Pfizer/BioNTech strike COVID-19 vaccine manufacturing deal with Biovac South Africa

SOUTH AFRICA – Pfizer Inc and BioNTech have entered into a deal with South Africa’s Biovac Institute to process and distribute over 100 million doses a year of their COVID-19 vaccine for the African Union starting 2022. Biovac, a public-private partnership focused on vaccine production, will receive COVID-19 vaccine drug substance made in plants in Europe, and will begin so-called fill-finish operations, the last stage of drug manufacturing and packaging, in 2022. The deal, under which the Cape Town-based Biovac Institute will fill vials of the Pfizer/BioNTech vaccine and ready…

Read More